Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Motor Neuron Disease, Amyotrophic Lateral Sclerosis clinical trials
2 of 2 indexed Motor Neuron Disease, Amyotrophic Lateral Sclerosis trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Motor Neuron Disease, Amyotrophic Lateral Sclerosis: 2 US clinical trials tracked, 2 recruiting.
Motor Neuron Disease, Amyotrophic Lateral Sclerosis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is ALS Therapy Development Institute, running 1 of these trials.
Enrollment posture brief
Registry condition motor-neuron-disease-amyotrophic-lateral-sclerosis
OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Motor Neuron Disease, Amyotrophic Lateral Sclerosis lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Motor Neuron Disease, Amyotrophic Lateral Sclerosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Motor Neuron Disease, Amyotrophic Lateral Sclerosis is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
ALS Research Collaborative
ALS Therapy Development Institute
NCT06885918
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
Nova Southeastern University
NCT07187388
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Motor Neuron Disease, Amyotrophic Lateral Sclerosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Motor Neuron Disease, Amyotrophic Lateral Sclerosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Motor Neuron Disease, Amyotrophic Lateral Sclerosis page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Motor Neuron Disease, Amyotrophic Lateral Sclerosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- ALS Therapy Development Institute sponsors the most Motor Neuron Disease, Amyotrophic Lateral Sclerosis trials on record, review their full trial history before evaluating a specific study. See ALS Therapy Development Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Motor Neuron Disease, Amyotrophic Lateral Sclerosis condition card totals 2 registered trials; most-linked intervention Transcutaneous Electrical Nerve Stimulation to reduce facial pain and improve jaw range of motion in ALS and PLS; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.